GMI Calculator: Mean Blood Glucose to Glucose Management Indicator (2026)
GMI (Glucose Management Indicator) formula explained: 3.31 + 0.02392 × mean glucose. Reference table in mg/dL and mmol/L, and when GMI differs from your lab A1C.

You attached the CGM, wore it for two weeks, and pulled up the ambulatory glucose profile. At the top of the page is a percentage labeled GMI. Three weeks later, your lab A1C comes back a full percentage point different. Neither number is wrong, and your clinician is not confused. They measure the same general phenomenon through completely different methods, and in some patients they will never fully align.
GMI stands for Glucose Management Indicator. The A1C Calculator converts mean blood glucose to an estimated A1C equivalent using the ADAG study equation. GMI uses a different linear equation published in a 2018 Diabetes Care paper by Bergenstal and colleagues, derived specifically from continuous glucose monitor sensor data rather than from lab hemoglobin readings. This guide explains what mean blood glucose means for your GMI, how the formula works in both mg/dL and mmol/L, and when the two percentages genuinely diverge.
What GMI Is and Why It Appears on CGM Reports
The Glucose Management Indicator is a real-time A1C estimate derived entirely from CGM sensor readings. It requires a minimum of 14 days of wear data and at least 70% sensor coverage to be considered valid. Dexcom Clarity labels it GMI, LibreView shows it as Estimated HbA1c in some report versions, and most endocrinology EHR integrations display it at the top of the standardized ambulatory glucose profile (AGP) report.
The reason GMI appears on CGM reports rather than a raw mean glucose number is clinical communication. Clinicians trained on decades of A1C targets can immediately interpret 7.0% in a way that 154 mg/dL does not communicate as intuitively at a glance. GMI translates the sensor's continuous glucose reading into a format that fits existing clinical decision frameworks without requiring a separate lab draw.
GMI is not a hemoglobin A1C measurement. It does not reflect glycated hemoglobin. It cannot be used to diagnose diabetes or to satisfy HbA1c-based criteria for insurance approvals. It is an estimate, and its accuracy relative to lab A1C varies based on individual physiology.
The formula producing GMI was validated in a population of 1,534 adults with type 1 and type 2 diabetes across multiple clinical trials. The study found GMI agreed with lab A1C within 0.5 percentage points in roughly 80% of participants. In the remaining 20%, a persistent offset between GMI and lab A1C reflects underlying conditions that alter red blood cell lifespan, not CGM malfunction.
The GMI Formula: Calculating Your Indicator from Mean Blood Glucose
The GMI equation is a single linear formula. Both the mg/dL and the mmol/L versions produce identical output when mean glucose is correctly expressed in each unit.
GMI (%) = 3.31 + 0.02392 × Mean Glucose (mg/dL)
GMI (%) = 3.31 + 0.4308 × Mean Glucose (mmol/L)
Worked example in mg/dL:
- Mean glucose from CGM over 14 days: 154 mg/dL
- GMI = 3.31 + (0.02392 × 154)
- GMI = 3.31 + 3.684
- GMI = 6.994% → displayed as 7.0%
Worked example in mmol/L:
- Mean glucose: 8.6 mmol/L
- GMI = 3.31 + (0.4308 × 8.6)
- GMI = 3.31 + 3.705
- GMI = 7.015% → displayed as 7.0%
The two examples match because 154 mg/dL and 8.6 mmol/L represent the same glucose concentration (the precise conversion is 1 mmol/L = 18.0182 mg/dL). Any CGM app displaying both units applies the same conversion internally.
Your CGM calculates mean glucose by averaging every sensor reading across the reporting period: roughly every 5 minutes for Dexcom and every 15 minutes for Libre. Over 14 days with continuous wear, a Dexcom G7 generates approximately 4,032 individual readings. The arithmetic mean of those readings is what the formula inputs.
The Blood Glucose to A1C Calculator uses the ADAG equation (Mean glucose = 28.7 × A1C − 46.7) rather than the Bergenstal GMI equation. Both are clinically validated for different purposes. The ADAG equation was built from lab A1C data. The Bergenstal equation was built from CGM sensor means. When your CGM gives you a mean glucose reading, use the GMI formula above. When your lab gives you an A1C and you want the corresponding mean glucose estimate, use the ADAG reverse.
GMI and Mean Blood Glucose Reference Table
The table below shows GMI output across the clinically relevant mean glucose range, from near-normal to significantly elevated. Use it as a lookup when your app shows mean glucose and you want the corresponding GMI without calculating manually.
| Mean Glucose (mg/dL) | Mean Glucose (mmol/L) | GMI (%) | Clinical Zone |
|---|---|---|---|
| 97 | 5.4 | 5.6% | Near normal |
| 111 | 6.2 | 5.9% | Prediabetes range |
| 126 | 7.0 | 6.3% | ADA prediabetes threshold |
| 140 | 7.8 | 6.7% | Below ADA target |
| 154 | 8.6 | 7.0% | ADA target threshold |
| 169 | 9.4 | 7.4% | Above target |
| 183 | 10.2 | 7.7% | Above target |
| 197 | 10.9 | 8.0% | Significantly above |
| 212 | 11.8 | 8.4% | Significantly above |
| 226 | 12.6 | 8.7% | High |
| 240 | 13.3 | 9.1% | High |
| 254 | 14.1 | 9.4% | High |
The ADA recommends an A1C target below 7.0% for most non-pregnant adults with diabetes, which corresponds to a mean glucose of approximately 154 mg/dL and a GMI of 7.0%. Individual targets vary based on hypoglycemia risk, age, comorbidities, and patient preference. Your clinician's recommendation takes precedence over any population-level benchmark.

When GMI and Lab A1C Give Different Results
About one in five people with diabetes has a persistent offset between GMI and their lab A1C. The offset is consistent across multiple measurements for the same individual, which indicates it reflects stable biology rather than sensor error or a single aberrant draw.
Conditions that lower lab A1C relative to actual glucose exposure:
Iron deficiency anemia and hemolytic anemia shorten red blood cell lifespan. With fewer days of RBC circulation, there is less time for glucose to glycate hemoglobin, producing a lower A1C than actual glucose levels would suggest. Hemoglobin variants, including HbS (sickle cell trait) and HbC, interfere with some A1C assay methods and produce lower or unreliable results depending on which laboratory method is used. Recent blood transfusion introduces donor red blood cells with no prior glycation history, diluting the glycated fraction. Chronic kidney disease with erythropoietin treatment accelerates RBC turnover, shortening lifespan and reducing A1C.
In all of these cases, GMI runs higher than lab A1C, and the GMI more accurately reflects true glucose burden.
Conditions that raise lab A1C relative to actual glucose exposure:
Iron or B12 supplementation can extend red blood cell lifespan, giving more time for glycation to accumulate. Splenectomy slows red blood cell destruction, extending lifespan and raising A1C. High altitude exposure alters oxygen-related RBC physiology in ways that can increase glycation rates independent of glucose levels.
In these cases, GMI runs lower than lab A1C, and GMI more reliably reflects current glucose levels.
Clinicians managing patients with conditions like CKD or hemoglobin variants often rely more heavily on CGM-derived metrics and the anion gap alongside other markers. The Anion Gap Calculator is used in exactly this context: metabolic acidosis, common in advanced CKD, independently affects insulin sensitivity and glucose utilization, making integrated assessment of multiple lab values necessary.
The practical implication for CGM users: if your GMI and lab A1C consistently differ by more than 0.5%, mention it at your next appointment. Your clinician can assess whether an underlying condition is driving the discordance and which number should guide treatment decisions.
How to Use Mean Glucose to Track Progress Between A1C Draws
Lab A1C is typically drawn every 3 months for patients not at target and every 6 months for those at stable, controlled levels. CGM mean glucose is available continuously. Using the 14-day mean glucose to monitor progress between appointments is one of the primary clinical advantages CGM offers over fingerstick monitoring alone.
Deriving a mean glucose target from your A1C goal:
If your clinician has set an A1C target, you can calculate the corresponding mean glucose using the ADAG equation reversed:
Target Mean Glucose (mg/dL) = (Target A1C × 28.7) − 46.7
For an A1C target of 7.0%: Mean glucose target = (7.0 × 28.7) − 46.7 = 200.9 − 46.7 = 154 mg/dL
For a 6.5% target: Mean glucose target = (6.5 × 28.7) − 46.7 = 186.55 − 46.7 = 140 mg/dL
Using weekly mean glucose to spot trends:
Most CGM apps display 7-day, 14-day, 30-day, and 90-day mean glucose. The 14-day mean produces the most stable GMI estimate. Tracking it weekly gives you a rolling view of whether glucose management is improving, holding, or drifting upward between lab appointments.
A shift of 13 mg/dL in mean glucose corresponds to roughly 0.3% in GMI. If your 14-day mean was 154 mg/dL last week and is 167 mg/dL today, your estimated GMI has moved from 7.0% toward 7.3%, a meaningful change worth reviewing current diet and activity patterns rather than waiting for the next quarterly draw.
The same principle of formula-adjusted clinical measurement appears in other contexts. The Corrected Calcium Formula adjusts a measured lab value for a confounding variable (albumin) to produce a more accurate clinical picture, exactly as GMI adjusts raw sensor readings for the CGM context.

GMI stands for Glucose Management Indicator. It is a real-time A1C estimate calculated from your CGM's mean blood glucose over a minimum 14-day sensor period. The formula is GMI (%) = 3.31 + 0.02392 × mean glucose in mg/dL. A mean glucose of 154 mg/dL produces a GMI of 7.0%. It appears automatically on Dexcom Clarity, LibreView, and ambulatory glucose profile reports. GMI is not a lab test and cannot replace a measured hemoglobin A1C for diagnosis or insurance documentation.
Use the formula: GMI (%) = 3.31 + 0.02392 × mean glucose in mg/dL. If your CGM shows a 14-day mean of 180 mg/dL, the calculation is: 3.31 + (0.02392 × 180) = 3.31 + 4.306 = 7.616%, which rounds to 7.6%. For mmol/L readings, the formula is: GMI (%) = 3.31 + 0.4308 × mean glucose in mmol/L. Both versions produce the same result when the mean glucose is correctly expressed in each unit.
Mean blood glucose is the arithmetic average of all glucose readings recorded over a specified period, typically 14 or 30 days from a CGM. A Dexcom device reading every 5 minutes generates roughly 4,032 readings across 14 days. A mean of 154 mg/dL corresponds to an estimated A1C of 7.0% and a GMI of 7.0%. The ADA's general target mean glucose for adults with diabetes is approximately 154 mg/dL or below, corresponding to an A1C at or under 7.0%.
For most patients, GMI and lab A1C agree within 0.5 percentage points. The Bergenstal 2018 validation study found about 51% of patients had GMI within 0.3% of their lab A1C, and roughly 80% were within 0.5%. The 20% with larger differences typically have conditions affecting red blood cell lifespan: anemia, hemoglobin variants, kidney disease, or recent transfusion. In those patients, GMI often reflects actual glucose exposure more accurately than lab A1C.
Most diabetes management guidelines target an A1C at or below 7.0% for non-pregnant adults, which corresponds to a GMI of 7.0% and a mean blood glucose of approximately 154 mg/dL. More aggressive targets of 6.5% correspond to a mean glucose of about 140 mg/dL and a GMI of 6.7%. Less strict targets for patients at high hypoglycemia risk may allow GMI up to 8.0%, corresponding to a mean glucose of approximately 197 mg/dL. Your clinician sets your specific target based on individual circumstances.
GMI and lab A1C measure different things: GMI reflects your CGM average glucose over 14 days, while lab A1C reflects glycation of hemoglobin over 90 to 120 days. Timing differences alone cause some divergence. Larger persistent gaps over 0.5% usually indicate altered red blood cell lifespan. Shorter RBC lifespan from anemia, sickle cell trait, or hemolytic conditions pushes lab A1C below GMI. Longer RBC lifespan from iron supplementation or splenectomy pushes lab A1C above GMI. A consistent gap across multiple draws is worth discussing with your endocrinologist.
Written by
Hassaan Rasheed
Web Developer & Content Researcher
Hassaan builds calculators and writes research-backed guides on finance, math, payroll, and construction topics. Every number in his articles is sourced from official data and worked through by hand.
View LinkedIn Profile

